Description
Delta Sleep-Inducing Peptide, commonly called DSIP or emideltide, is an investigational nine-amino-acid peptide first studied for its possible influence on sleep-related brain activity and sleep-wake regulation.
Early research explored whether DSIP could affect delta-wave activity, sleep onset, sleep continuity, sleep patterns, and daytime functioning. Current findings remain mixed and preliminary, and individual experiences may vary.
This 12-week supply is intended for eligible patients following a medical evaluation. A licensed provider will review your health history, sleep concerns, current medications, and individual goals before determining whether DSIP is appropriate for you. If prescribed, use it exactly as directed. DSIP is not a replacement for proper evaluation or established treatment of insomnia, sleep apnea, narcolepsy, or another sleep disorder.





Reviews
There are no reviews yet.